Justin Gainor, MD

Researcher | 2016

Justin Gainor, MD, a thoracic oncologist at the Mass General Cancer Center, conducts intensive research on developing novel targeted therapies for patients with genetically-defined forms of lung cancer and designs clinical trials to evaluate these complex, life-saving treatments.

Concurrently, he is delving into the role of the immune system as a means to combat cancer. In recent years, immunotherapies targeting the PD-1 protein have reshaped the management of a number of malignancies. Dr. Gainor is now spearheading Mass General’s clinical trials assessing similar strategies in lung and esophageal cancer. Lastly, he is exploring the intersection of targeted therapies and immunotherapy, both on a clinical and translational level.

Thoracic cancer patients struggling to beat their disease benefit both from Dr. Gainor’s advanced research and his dedicated clinical care, as well as his random acts of kindness, which his colleague Kimberly Lewis, NP, has witnessed firsthand.

Says Kimberly: “Dr. Gainor is making a difference in the fight against cancer not only through his skill and talent as a researcher, but also by his generosity and patience as an attending physician.”

Meet two researchers at the Mass General Cancer Center who are activating the human immune system to target cancer within the body. Justin Gainor, MD, Nir Hacohen, PhD and 98 other caregivers, researchers, philanthropists, advocates and volunteers were honored as part of the one hundred in 2016 for their commitment to changing how we fight cancer.

Created and supported by the Mass General Cancer Center, the one hundred is an awareness and fundraising initiative that celebrates hope in the cancer community.

Story told by Jordan Rich of The Jordan Rich Show on WBZ NewsRadio 1030. Visit www.theonehundred.org to learn more and meet the rest of our honorees.

Show more Honorees